Car Nk
Anti-BCMA CAR-NK
Anti-BCMA CAR-NK is flagged as a platform signal because it has an active early-phase oncology cell-therapy trial at Shahid Beheshti University of Medical Sciences, with a possible patent signal linked through modality_match. Manual review is still required.
Phase1 · Not Yet Recruiting
View asset